Cite

HARVARD Citation

    Macaluso, F. et al. (n.d.). P288 Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn's Disease. Journal of Crohn's and colitis. p. S320. [Online]. 
  
Back to record